The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze
Abstract
Rationale Drugs that reduce relapse in alcoholics are thought to inhibit either positive reinforcement for drinking (e.g. naltrexone) or negative reinforcement (e.g. acamprosate), and may reduce the impact of conditioned stimuli associated with previous alcohol use. We have developed a model for such conditioning by repeatedly pairing ethanol administration with plus-maze exposure. Substitution of saline for ethanol greatly increased stretched-attend postures and time in the central square, conditioned to the environment. Objective To test the hypothesis that if this behaviour indicates a negative affective state caused by the expectation of ethanol, it should be inhibited by drugs that reduce negative, but not positive, reinforcement. Methods The effects of naltrexone and acamprosate on alcohol-conditioned abstinence behaviour were compared. Results Acute administration of either drug alone produced no significant effects on plus-maze behaviour in naive mice. Naltrexone had no significant effect on the alcohol-conditioned abstinence behaviour, but acamprosate reduced the incidence of stretched-attend postures. Conclusions The experiments replicated previous findings for alcohol/environment conditioned behaviour, and demonstrated, as predicted, that this was decreased by acamprosate but not by naltrexone. Effects of acamprosate on conditioned negative reinforcement may be the cause of this effect, but more work is required to establish the usefulness of this model in evaluati…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acamprosate was developed from animal models of dependence-induced drinking (Le Magnen et al., 1987) and also blocked hyperkatifeia that was associated with alcohol withdrawal in rodent models (Cole et al., 2000).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Cole et al., 2000
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain
Solomon, R. L. (1980) · American Psychologist · doi:10.1037/0003-066x.35.8.691 · Cited by 1,194 · cited 2×
“In this hypothesis, relapse is presumed to occur commonly in response to cues (external or internal) previously associated with alcohol drinking ( Solomon 1980 ).”
BackgroundRodgers, R. J., & Johnson, N. J. T. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00138-m · Cited by 791 · cited 1×
“Effects on conditioned behaviour by this mechanism are entirely consistent with the role of NMDA receptors in conditioned associative learning (see Ono et al. 1995 ), including conditioned place preference to opiate drugs (Tzschentke and Schmidt 1995).”
BackgroundAnxiogenic stimuli in the elevated plus-maze
Treit, D., Menard, J., & Royan, C. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90492-c · Cited by 628 · cited 1×
“As previous work has shown the importance of thigmotactic cues provided by the walls of the maze ( Treit et al. 1993 ), head-dipping, rears and stretched-attend postures were differentiated as “unprotected” (occurring on/from the open arms) or “protected” (occurring on/from the relative security of the central platfor…”
BackgroundRelapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479 · cited 1×
“…two pharmacotherapies have performed successfully in clinical trials, and these drugs offer considerable hope for a reduced incidence of relapse in the future: they are the opiate antagonist, naltrexone (Volpicelli et al. 1992), and the homotaurine derivative, acamprosate (Sass et al. 1996).”
BackgroundAnti-craving compounds for ethanol: new pharmacological tools to study addictive processes
Spanagel, R., & Zieglgänsberger, W. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)89800-8 · Cited by 291 · cited 4×
“For this reason, it has been proposed that inhibitory effects of the drugs against alcohol reinforcement extend to conditioned reinforcement for drinking behaviour (Littleton 1995; Spanagel and Ziegelgansberger 1997).”
BackgroundInfluentialAcamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
Spanagel, R., Hölter, S. M., Allingham, K., Landgraf, R., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00174-4 · Cited by 274 · cited 5×
“Both drugs significantly reduce the incidence of relapse drinking during abstinence, and seem also to reduce the severity of relapse if it occurs ( Spanagel and Ziegelgansberger 1997 ).”
BackgroundResultInfluentialAcamprosate in alcohol dependence: how does it work?
LITTLETON, J. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 178 · cited 4×
“For this reason, it has been proposed that inhibitory effects of the drugs against alcohol reinforcement extend to conditioned reinforcement for drinking behaviour (Littleton 1995; Spanagel and Ziegelgansberger 1997).”
BackgroundInfluentialSelf-citationZeise, M. L., Kasparov, S., Capogna, M., & Zieglgänsberger, W. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90682-8 · Cited by 175 · cited 1×
“The mechanism for this effect of acamprosate is unknown, but recently reported modulatory effects on NMDA receptors are consistent with the effect (Zeise et al. 1993; Al Qatari et al. 1998; Berton et al. 1998; Naassila et al. 1998).”
BackgroundCole, J. C., & Rodgers, R. J. (1994) · Psychopharmacology · doi:10.1007/bf02244851 · Cited by 171
Self-citationWhat is a relapse? Fifty ways to leave the wagon
Miller, W. R. (1996) · Addiction · doi:10.1046/j.1360-0443.91.12s1.6.x · Cited by 168 · cited 2×
“In contrast, the maintenance of abstinence, once detoxification has been achieved, is much more difficult, and the great majority of patients soon relapse back into heavy drinking ( Miller 1996 ).”
BackgroundNaassila, M., Hammoumi, S., Legrand, E., Durbin, P., & Daoust, M. (1998) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199806000-00005 · Cited by 164 · cited 3×
“The mechanism for this effect of acamprosate is unknown, but recently reported modulatory effects on NMDA receptors are consistent with the effect (Zeise et al. 1993; Al Qatari et al. 1998; Berton et al. 1998; Naassila et al. 1998 ).”
BackgroundResultAmygdala role in conditioned associative learning
Ono, T., Nishijo, H., & Uwano, T. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00008-j · Cited by 132
Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat
Spanagel, R., Putzke, J., Stefferl, A., Schöbitz, B., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00175-6 · Cited by 100
File, S. E., Andrews, N., Wu, P. Y., Zharkovsky, A., & Zangrossi, H. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90141-p · Cited by 76 · cited 1×
“File et al. (1992) , for example, found changes in GABA transmission after handling and exposure to a plus-maze, but such a possibility requires further investigation.”
BackgroundManagement Of The Alcohol Withdrawal Syndrome
Romach, M. K., & Sellers, E. M. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.001543 · Cited by 67
Cole, J. C., Burroughs, G. J., Laverty, C. R., Sheriff, N. C., Sparham, E. A., & Rodgers, R. J. (1995) · Psychopharmacology · doi:10.1007/bf02245943 · Cited by 57
Self-citationNaltrexone and the Treatment of Alcohol Dependence.
Volpicelli, J. R., Clay, K. L., Watson, N. T., & Volpicelli‐Daley, L. A. (1994) · PubMed Central · Cited by 44
Cited by
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 412
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Acamprosate was developed from animal models of dependence-induced drinking (Le Magnen et al., 1987) and also blocked hyperkatifeia that was associated with alcohol withdrawal in rodent models (Cole et al., 2000).”
BackgroundGianoulakis, C. (2001) · PubMed · Cited by 236
Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action
De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005) · CNS Drugs · doi:10.2165/00023210-200519060-00004 · Cited by 201
Self-citationVassiljev, V. (2004) · DSpace repository (University of Tartu) · Cited by 176
Metadata
- Authors
- Cole, J. C., Littleton, J. M., & Little, H. J.
- Affiliations
- Durham University (GB)
- University of Kentucky (US)
- Venue
- Psychopharmacology
- Published
- 2000-01-10
- Volume
- 147
- Issue
- 4
- Pages
- 403-411
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1993776646
- Cited by
- 65
- References
- 18
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2012: 6
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- acamprosate, naltrexone, alcohol relapse, negative reinforcement, positive reinforcement, elevated plus maze, alcoholism treatment, alcohol expectancies
- MeSH terms
- Acamprosate, Alcohol Deterrents, Ethanol, Animals, Anxiety, Central Nervous System Depressants, Exploratory Behavior, Male, Naltrexone, Substance Withdrawal Syndrome, Taurine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.